United States
Drmennobgyn is a U.S.-based OB-GYN and menopause specialist who operates at the intersection of clinical authority and lived patient experience.
Total Followers +0.7%
227K
Across Instagram
Primary Platform
YouTube
227K followers · 100% of audience
Engagement
1.2%
vs. 1.5% category median
Sponsorship Tier
Mid
Est. $4.5K–$11K / IG post
Dr. Menn was present at HHS when the FDA announced changes to long-standing hormone therapy warning language in early 2026, then joined the podcast to contextualize decades of misinformation around HRT and breast cancer risk for a general audience.
Dr. Menn spoke with prominent menopause advocate Tamsen Fadal about why younger women and breast cancer survivors are "dismissed the fastest" when seeking menopause care, drawing on her own experience navigating menopause multiple times.
| Platform | Followers | 30d Growth | Engagement | Posts / wk | Last upload |
|---|---|---|---|---|---|
| 227,223 | +2K | 1.2% | 8.6 | 12 days ago |
| Window | Combined | |||
|---|---|---|---|---|
| Last 7 days | +295 +0.1% | +0 +0.0% | +0 +0.0% | +295 |
| Last 30 days | +2K +0.7% | +0 +0.0% | +0 +0.0% | +2K |
| Last 90 days | +11K +4.7% | +0 +0.0% | +0 +0.0% | +11K |
| Last 365 days | +11K +4.7% | +0 +0.0% | +0 +0.0% | +11K |
Daily follower snapshots from CreatorDB's longitudinal index.
Drmennobgyn is a U.S.-based OB-GYN and menopause specialist who operates at the intersection of clinical authority and lived patient experience. Her practice centers on telehealth education and consultations, with a particular focus on premature menopause, perimenopause, primary ovarian insufficiency (POI), and breast cancer survivorship. What distinguishes her from other physician-creators is a deeply personal foundation: she was diagnosed with breast cancer at age 28 and subsequently navigated premature menopause herself — a dual experience she documents openly, including the realities of hormone therapy decisions, Venlafaxine withdrawal management, and survivorship care. This first-person clinical voice, backed by specialist credentials, gives her content a credibility that purely educational or purely personal accounts rarely achieve.
Her Instagram audience skews notably younger than one might expect for a menopause-focused account — a pattern almost certainly driven by her POI and premature menopause content, which speaks directly to women in their twenties and thirties facing early hormonal disruption. The near-even gender split in her audience suggests her educational framing draws in partners, caregivers, and medically curious viewers beyond her primary patient demographic. Her Substack presence points toward a content strategy built for depth, not just scroll-stopping video. For brands in women's health, telehealth platforms, hormone wellness, or oncology survivorship, she represents a credible mid-tier voice with a defined clinical identity — a positioning that becomes more valuable as the menopause wellness category continues its mainstream expansion.
Drmennobgyn reaches an audience concentrated in United States primarily through YouTube, and is best activated via Instagram Reels and Stories. As a health creator they map naturally to brands targeting that space. With no brand deals logged yet, they read as an available, category-aligned partner for advertisers building early presence in the space. Engagement on YouTube runs around 1.2%, which points to an audience better suited to category-relevant, mid-funnel campaigns than to pure-reach buys. Their YouTube-first format lends itself to integrations that sit inside the creator's usual content rather than running as standalone ads. Because the audience follows health content rather than arriving through untargeted reach, sponsorships that match the channel's subject matter tend to convert more efficiently than broad placements. A consistent, on-topic posting focus gives sponsors a predictable, brand-safe environment, lowering placement risk compared with broad, general-interest channels. Campaigns here are best measured on qualified engagement and consideration within the niche rather than on raw impression volume. For United States-focused brands in health and related categories, Drmennobgyn offers a defined, creative-fit audience rather than broad, low-intent impressions.
Benchmark estimates for a creator at Drmennobgyn's tier (Mid, 227K combined followers, United States). Pulled from CreatorDB's category benchmarks.
The CreatorDB Agency runs end-to-end influencer campaigns globally — shortlisting, outreach, contracting, and performance reporting. Talk to our team about building a campaign around creators in this niche.
Yes. She has shared publicly that she was diagnosed with breast cancer at age 28, roughly 25 years ago. That personal history directly shapes her work in breast cancer survivorship and her focus on the long-term hormonal health consequences — including premature menopause — that many survivors face.
Yes. She has stated in her own content that estrogen-dosing guidelines for premature menopause apply to her personally, meaning she lives with the condition as both a clinician and a patient. This dual perspective is central to how she frames her education and why her audience finds her credible.
She is a credentialed OBGYN and Menopause Specialist, not simply a health content creator. Her clinical work includes telehealth consultations in addition to her educational social media presence, which covers perimenopause, hormonal health, and breast cancer survivorship.
Yes. She posted about managing her personal Venlafaxine withdrawal, describing in detail what the process required. Venlafaxine is an SNRI sometimes used as a non-hormonal option for menopausal symptoms, so her firsthand account carries particular relevance for her audience of patients and survivors.
POI stands for Primary Ovarian Insufficiency, a condition where the ovaries stop functioning normally before age 40, often triggering premature menopause. Because she personally lives with premature menopause, POI is one of the core topics she covers from both a clinical and lived-experience standpoint.
Yes. Beyond her educational social media content, she explicitly offers telehealth and education consultations focused on menopause, perimenopause, hormonal health, and breast cancer survivorship. Patients looking for a menopause specialist with personal survivor experience can reach her through those consult services.
Yes. She directs her audience to her Substack for longer-form recordings and full conversations that go deeper than short-form social media allows. It functions as an extension of her education platform for patients who want detailed clinical discussions.
Her specialization in survivorship is rooted in her own diagnosis with breast cancer at age 28. As an OBGYN and Menopause Specialist, she now helps survivors navigate the gynecologic and hormonal challenges — particularly premature menopause — that frequently follow cancer treatment.
Based on her own public posts, she was diagnosed with breast cancer at age 28 approximately 25 years ago, placing her in her early-to-mid 50s as of 2026. She is openly transparent about her age and health timeline, which grounds her advice for midlife and perimenopausal women.
Her largest and most engaged audience is on Instagram, where she has built a following of well over 200,000 people through educational short-form content on menopause, perimenopause, and survivorship. She also publishes on YouTube and maintains a Substack for longer conversations.
Stats (followers, engagement, audience demographics, growth) are pulled live from the CreatorDB API covering YouTube, Instagram and TikTok. Bio and FAQ content is AI-assisted; news items are sourced from cited public press at generation time. Read the full methodology →
If you'd like to update, correct, or remove this profile, get in touch and we'll handle it within 5 business days. We don't publish private data — every stat shown comes from your public platform profiles.
@drmennobgyn · YouTube
+0 new followers
Preparing fresh data…
This usually takes 15–25 seconds.